{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-006975","form_type":"8-K","ticker":"BCPC","cik":"0000009326","company_name":"BALCHEM CORP","filed_at":"2025-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.860839+00:00","generated_at":"2026-05-26T07:51:38.389434+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Balchem Q4 record net sales $240M, adjusted EBITDA $62.8M, EPS $1.03","bullets":["Q4 net sales record $240.0M (+4.9% YoY); GAAP EPS $1.03 vs $0.82; adjusted EPS $1.13 vs $0.95.","Q4 adjusted EBITDA record $62.8M (+13.4%); free cash flow $39.8M.","Full-year record net sales $953.7M (+3.4%); GAAP EPS $3.93 vs $3.35; adjusted EPS $4.37 vs $4.00.","Full-year adjusted EBITDA record $250.3M (+8.4%); operating cash flow $182.0M.","Dividend increased double-digits; debt reduced by $119.6M in FY2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-006975","json":"https://secwatch.observer/filing/0001628280-25-006975.json","markdown":"https://secwatch.observer/filing/0001628280-25-006975.md","text":"https://secwatch.observer/filing/0001628280-25-006975.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/9326/000162828025006975/0001628280-25-006975-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/9326/000162828025006975/bcpc-20250221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T07:51:38.389434+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}